14 commercial payer policies list S2095. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
14 policies from 12 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of S2095 |
|---|---|---|
| Cigna Commercial Radiation Oncology Code List | Mar 7, 2026 | Prior auth required |
| Cigna Comprehensive Code List | Mar 7, 2026 | Prior auth required |
| Policy | Effective | Status of S2095 |
|---|---|---|
| Cigna Commercial & Medicare Advantage Radiation Oncology Code List | Jan 1, 2026 | Prior auth required |
| Cigna OBM Radiation Oncology Code List |
| Jan 1, 2026 |
| Prior auth required |
| Policy | Effective | Status of S2095 |
|---|---|---|
| Cryosurgical, Radiofrequency, Microwave, or Percutaneous Ethanol Ablation to Treat Solid Tumors in the Liver | Apr 15, 2026 | Covered |
| Policy | Effective | Status of S2095 |
|---|---|---|
| Radioembolization for Primary and Metastatic Tumors of the Liver | Nov 15, 2025 | Covered |
| Policy | Effective | Status of S2095 |
|---|---|---|
| Radioembolization for Primary and Metastatic Tumors of the Liver | Nov 15, 2025 | Covered |
| Policy | Effective | Status of S2095 |
|---|---|---|
| Radioembolization for Primary and Metastatic Tumors of the Liver | Nov 15, 2025 | Covered |
| Policy | Effective | Status of S2095 |
|---|---|---|
| Radioembolization for Primary and Metastatic Tumors of the Liver | Nov 15, 2025 | Covered |
| Policy | Effective | Status of S2095 |
|---|---|---|
| GHI/Emblem Non-City of New York & Medicare Radiation Oncology Code List | Jan 1, 2026 | Prior auth required |
| Policy | Effective | Status of S2095 |
|---|---|---|
| Health Partners Plans Radiation Therapy Code List | Jan 1, 2025 | Prior auth required |
| Policy | Effective | Status of S2095 |
|---|---|---|
| Transarterial Radioembolization (TARE)/ Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver | Jan 1, 2026 | Covered |
| Policy | Effective | Status of S2095 |
|---|---|---|
| Transarterial Radioembolization (TARE)/ Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver | Jan 1, 2026 | Covered |
| Policy | Effective | Status of S2095 |
|---|---|---|
| Transarterial Radioembolization (TARE)/ Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver | Jan 1, 2026 | Covered |